NRX Pharmaceuticals Inc (NRXP)
Healthcare
Biotechnology
3.20 $
+1.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns NRX Pharmaceuticals Inc (NRXP)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 73.0% of the shares are freely tradable; institutional investors hold 17.5%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
17.5%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
7.6%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
73.0%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
13.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
43Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| B Group, Inc | 8.28 | 3,000,000 | +0.0 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.20 | 1,160,184 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 2.01 | 729,842 | +36.4 | 12/31/2025 |
| AdvisorShares Investments, LLC | 1.16 | 420,467 | +28.2 | 03/31/2026 |
| Commonwealth Equity Services Inc | 1.10 | 397,431 | +8.4 | 03/31/2026 |
| Geode Capital Management, LLC | 0.86 | 310,112 | +41.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.35 | 744,532 | +0.0 | 04/30/2026 |
| AdvisorShares Psychedelics ETF | 1.99 | 632,093 | +0.0 | 05/29/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.02 | 324,194 | +0.0 | 04/30/2026 |
| Fidelity Extended Market Index | 0.54 | 171,876 | -0.4 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.